Home LiteratureArticle Details
PMID: 8069234 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Slow-binding inhibition of sialidase from influenza virus.

Biochemistry and molecular biology international ·Vol. 32 ·No. 5 ·1994-04-00 ·Pages 851-8

Pegg MS, von Itzstein M

Abstract

Sialidase from influenza virus A (Tokyo/3/67, N2) is inhibited in slow-binding fashion by 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid. The Ki observed for the tightly-bound form at steady-state is 3 x 10(-11) M. Slow-binding, which is a consequence of the guanidinyl moiety of the inhibitor, is observed only for influenza virus A sialidase and not for influenza virus B or any other viral, bacterial, or mammalian sialidase investigated. The different results obtained for sialidases from influenza virus A and B, whose active sites are conserved, point to the involvement of the expulsion of a structural water molecule in the slow-binding mechanism.

MeSH Terms
Antiviral Agents/metabolism,pharmacology Guanidines Influenza A virus/enzymology Molecular Structure Neuraminidase/antagonists & inhibitors Protein Binding Pyrans Sialic Acids/metabolism,pharmacology Time Factors Water/chemistry Zanamivir
Chemicals
Antiviral Agents Guanidines Pyrans Sialic Acids Water Neuraminidase Zanamivir
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Pegg M S
School of Pharmaceutical Chemistry, Victorian College of Pharmacy, Monash University, Parkville, Australia.
von Itzstein M
Article Info
Journal
Biochemistry and molecular biology international
Abbr.
Biochem Mol Biol Int
ISSN
1039-9712
Published
1994-04-00
Pages
851-8
Language
English
Region
England
NLM ID
9306673
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com